CIK 0001426800 · Non-accelerated filer<br>Smaller reporting company
ASSEMBLY BIOSCIENCES, INC.
Sign in to watch- Ticker
- ASMB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (833) 409-4583
- Business address
- TWO TOWER PLACE, 7TH FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- VENTRUS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $237,648
- in 4 filings
Net −$237,648. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-16 | Bjorkquist Jeanette M Principal Accounting Officer | Grant or award · Stock Option (right to buy) | +2,000 | 2,000 | ||
| 2023-02-16 | Delaney William E IV Chief Scientific Officer | Grant or award | +10,000 | 88,919 | ||
| 2023-02-16 | Okazaki Jason A CEO and President | Grant or award | +12,500 | 107,114 | ||
| 2022-08-08 | McHutchison John G Chief Executive Officer | Sale | −12,314 | $2.13 | $26K | 192,515 |
| 2022-08-01 | Delaney William E IV Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2022-08-01 | Okazaki Jason A President & COO | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2022-07-25 | Samar Michael P. Chief Financial Officer | Sale | −2,020 | $2.22 | $4K | 77,228 |
| 2022-05-31 | Delaney William E IV Chief Scientific Officer | Sale | −4,164 | $1.92 | $8K | 76,419 |
| 2022-05-25 | Mahony Susan Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-05-25 | Johnson-Pratt Lisa Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-05-25 | Houghton Michael Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-05-25 | DiMarchi Richard D Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-05-25 | Consylman Gina Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-05-25 | ALTIG ANTHONY E Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-05-25 | RINGO WILLIAM R Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-03-30 | Samar Michael P. Chief Financial Officer | Sale | −2,285 | $2.17 | $5K | 76,748 |
| 2022-03-30 | Stamm Luisa M Chief Medical Officer | Sale | −1,038 | $2.17 | $2K | 40,315 |
| 2022-03-30 | Delaney William E IV Chief Scientific Officer | Sale | −1,038 | $2.17 | $2K | 78,083 |
| 2022-03-30 | Okazaki Jason A Chief Operating Officer | Sale | −1,269 | $2.17 | $3K | 94,614 |
| 2022-03-30 | McHutchison John G CEO and President | Sale | −4,614 | $2.17 | $10K | 204,829 |
Page 8 of 15 · 297 trades